Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
1.440
-0.060 (-4.00%)
At close: Oct 29, 2024, 4:00 PM
1.560
+0.120 (8.33%)
After-hours: Oct 29, 2024, 5:56 PM EDT

Chemomab Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018
Period Ending
Oct '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
Market Capitalization
2163779--
Upgrade
Market Cap Growth
-10.71%-83.65%-53.12%---
Upgrade
Enterprise Value
8-15-915--
Upgrade
Last Close Price
1.440.513.206.90--
Upgrade
PE Ratio
--0.25-1.32-5.74--
Upgrade
PB Ratio
2.070.351.021.28--
Upgrade
P/FCF Ratio
-0.80-0.26-1.80-6.24--
Upgrade
P/OCF Ratio
-0.80-0.26-1.81-6.36--
Upgrade
EV/EBITDA Ratio
0.160.600.33-1.20--
Upgrade
EV/EBIT Ratio
0.160.600.33-1.19--
Upgrade
EV/FCF Ratio
0.160.650.46-1.17--
Upgrade
Debt / Equity Ratio
0.040.020.010.010.040.02
Upgrade
Debt / FCF Ratio
-0.02-0.02-0.01-0.03-0.08-0.03
Upgrade
Quick Ratio
3.114.155.9823.158.9518.81
Upgrade
Current Ratio
3.124.326.1823.669.0018.85
Upgrade
Return on Equity (ROE)
-93.80%-91.02%-56.60%-34.53%-51.36%-80.65%
Upgrade
Return on Assets (ROA)
-46.18%-48.80%-33.20%-20.12%-29.12%-46.48%
Upgrade
Return on Capital (ROIC)
-61.70%-59.12%-36.30%-21.16%-31.37%-49.81%
Upgrade
Earnings Yield
-72.53%-401.76%-74.96%-15.86%--
Upgrade
FCF Yield
-78.01%-391.70%-55.41%-16.03%--
Upgrade
Buyback Yield / Dilution
-19.04%-3.26%-9.70%-51.71%--
Upgrade
Total Shareholder Return
-19.04%-3.26%-9.70%-51.71%--
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.